executive_orderEvent Saturday, April 18, 2026Analyzed

Executive Order: Accelerating Medical Treatments for Serious Mental Illness

Bullish

Summary

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.FDA Commissioner to provide National Priority Vouchers to appropriate psychedelic drugs with Breakthrough Therapy designation.
  • 2.FDA and DEA to establish a pathway for eligible patients to access psychedelic drugs under the Right to Try Act, including Schedule I handling authorizations.
  • 3.HHS to allocate at least $50 million to support state governments advancing psychedelic drug programs.
  • 4.HHS, FDA, and VA to collaborate with the private sector to increase clinical trial participation and data sharing for psychedelic drugs.
  • 5.Attorney General to initiate and complete timely review for rescheduling of Schedule I substances that successfully complete Phase 3 clinical trials for serious mental health disorders.

Market Implications

This action is expected to significantly accelerate the development, approval, and patient access to psychedelic-based therapies for mental health, creating a more favorable regulatory and funding environment for companies in this nascent industry.

Full Analysis

This action is expected to significantly accelerate the development, approval, and patient access to psychedelic-based therapies for mental health, creating a more favorable regulatory and funding environment for companies in this nascent industry.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →